Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9 Charles A. GermanMichael D. Shapiro Leading Article 28 November 2019 Pages: 1 - 9
The Therapeutic Potential of Nanobodies Ivana JovčevskaSerge Muyldermans Review Article Open access 04 November 2019 Pages: 11 - 26
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents Vibeke StrandJoao GonçalvesJohn D. Isaacs Review Article Open access 13 November 2019 Pages: 27 - 37
Current Considerations on Characterization of Immune Response to Multi-Domain Biotherapeutics Boris GorovitsKun PengArno Kromminga Review Article 22 October 2019 Pages: 39 - 54
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study Ylenia IngrasciottaValeria BelleudiOn behalf of the Italian Biosimilars Network (I-BioNetwork) Original Research Article 08 October 2019 Pages: 55 - 64
Comparative Physicochemical and Biological Characterisation of the Similar Biological Medicinal Product Teriparatide and Its Reference Medicinal Product Piroska KovácsTamás SchäferZoltán Urbányi Original Research Article Open access 08 October 2019 Pages: 65 - 75
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar Thomas F. LerchPenelope SharpeHugh D. Conlon Original Research Article Open access 24 October 2019 Pages: 77 - 87
Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry Hyoun-Ah KimEunyoung LeeKichul Shin Original Research Article Open access 16 November 2019 Pages: 89 - 98
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Yaerim KimSu-Kil ParkKyubok Jin Original Research Article 20 November 2019 Pages: 99 - 110